Table 1.

Percentages of viability of MCF7 cells exposed to different concentrations of ceranib-2 for 24 h

Applied ceranib-2 doses (µM)	Percentage of viability	Standard deviation (±)
0	100.00	0.00
10	52.30	0.89
20	32.89	1.01
30	24.23	1.00
40	23.11	0.55
50	21.44	0.99
60	18.92	1.23
70	7.12	1.56
80	4.82	0.78
90	8.73	1.47
100	8.03	1.03